Sakagami H, Satoh K, Kochi M
Department of Dental Pharmacology, Meikai University School of Dentistry, Saitama, Japan.
Anticancer Res. 1997 Nov-Dec;17(6D):4451-2.
This review summarizes our comparative study of the antitumor action of sodium 5,6-benzylidene-L-ascorbate (SBA) and sodium ascorbate. Both SBA and ascorbate produced ascorbate radicals during decomposition, elevated oxidation potential and oxidized methionine to methionine sulfoxide, in the regular culture medium. They induced apoptotic cell death (characterized by internucleosomal DNA fragmentation) in human myelogenous leukemic cell lines, but killed most of other tumor cell lines by necrosis without induction of internucleosomal DNA fragmentation. The cytotoxic activity of SBA and ascorbate was significantly enhanced in the presence of copper and the stimulation effect of copper was reduced by a heavy metal antagonist. However, the cytotoxic activity of SBA was only slightly modified by iron, cysteine analog or catalase, in contrast to ascorbate, which was highly sensitive to all these agents. Furthermore, intravenous administration of SBA induced degeneration in chemically-induced hepatocellular carcinoma whereas ascorbate was inactive. These data suggest the differential mode of antitumor action between these two compounds.
本综述总结了我们对5,6-亚苄基-L-抗坏血酸钠(SBA)和抗坏血酸钠抗肿瘤作用的比较研究。在常规培养基中,SBA和抗坏血酸在分解过程中都会产生抗坏血酸自由基,提高氧化电位,并将甲硫氨酸氧化为甲硫氨酸亚砜。它们在人髓性白血病细胞系中诱导凋亡性细胞死亡(以核小体间DNA片段化为特征),但通过坏死杀死大多数其他肿瘤细胞系,而不诱导核小体间DNA片段化。在铜存在的情况下,SBA和抗坏血酸的细胞毒性活性显著增强,重金属拮抗剂可降低铜的刺激作用。然而,与对抗坏血酸高度敏感的抗坏血酸不同,SBA的细胞毒性活性仅受到铁、半胱氨酸类似物或过氧化氢酶的轻微影响。此外,静脉注射SBA可导致化学诱导的肝细胞癌发生变性,而抗坏血酸则无活性。这些数据表明这两种化合物的抗肿瘤作用方式不同。